Clinical trial
The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic…
NCT00405665 · The Hospital for Sick Children, Other · Completed
Key facts
| NCT number | NCT00405665 |
|---|---|
| Title | The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis |
| Official title | Pilot Study of the Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis |
| Lead sponsor | The Hospital for Sick Children, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | L-arginine |
| Enrollment | 20 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Nov 30, 2006 |
| Last update posted | Sep 2, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: